HashiCorp Inc (HCP) concluded trading on Wednesday at a closing price of $33.76, with 3.55 million shares of worth about $119.87 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 43.48% during that period and on October 16, 2024 the price saw a loss of about -0.30%. Currently the company’s common shares owned by public are about 202.89M shares, out of which, 150.31M shares are available for trading.
Stock saw a price change of -0.50% in past 5 days and over the past one month there was a price change of -0.53%. Year-to-date (YTD), HCP shares are showing a performance of 42.81% which increased to 53.59% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $18.91 but also hit the highest price of $34.06 during that period. The average intraday trading volume for HashiCorp Inc shares is 2.27 million. The stock is currently trading -0.36% below its 20-day simple moving average (SMA20), while that difference is down -0.22% for SMA50 and it goes to 12.51% higher than SMA200.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
HashiCorp Inc (NASDAQ: HCP) currently have 202.89M outstanding shares and institutions hold larger chunk of about 55.73% of that.
The stock has a current market capitalization of $6.85B and its 3Y-monthly beta is at 1.25. It has posted earnings per share of -$0.75 in the same period. It has Quick Ratio of 3.59 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for HCP, volatility over the week remained 0.40% while standing at 0.35% over the month.
Stock’s fiscal year EPS is expected to rise by 394.41% while it is estimated to increase by 42.80% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Citigroup on September 03, 2024 offering a Neutral rating for the stock and assigned a target price of $35 to it. On March 19, 2024, KeyBanc Capital Markets Initiated their recommendations, while on March 12, 2024, Scotiabank Upgrade their ratings for the stock with a price target of $31. Stock get an Overweight rating from Morgan Stanley on February 26, 2024.
